You just read:

In the CKD-MBD Market, OPKO's Rayaldee Continues to Struggle While Keryx's Auryxia Gains Momentum, According to Latest Quarterly Update from Spherix Global Insights

News provided by

Spherix Global Insights

Nov 14, 2017, 09:21 ET